Neisseria meningitidis serogroups A and C capsular polysaccharides — Drug Target

All drugs that target Neisseria meningitidis serogroups A and C capsular polysaccharides — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Polysaccharide conjugate vaccine · Conjugate vaccine

Marketed (1)

• Meningococcal A+C vaccine · Sanofi Pasteur, a Sanofi Company · Polysaccharide conjugate vaccine · Immunology / Infectious Disease
  This vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis serogroups A and C polysaccharide antigens.

Phase 3 pipeline (1)

• MenAC conjugate vaccine · Sanofi · Conjugate vaccine · Immunology / Infectious Disease
  MenAC conjugate vaccine stimulates the immune system to produce antibodies against meningococcal serogroups A and C by conjugating polysaccharide antigens to a protein carrier.